Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Dosage Regimen Designs: Nomograms and Tabulations

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

'Go into it with your eyes open': A reflexive thematic analysis of the experiences of partners of individuals who have had metabolic and bariatric surgery.

British journal of health psychology·2026

Same author

An exploratory investigation into how community pharmacists deal with drug shortages: interview study.

The International journal of pharmacy practice·2026

Same author

Interventions for reducing antimicrobial resistance in livestock in sub Saharan Africa: systematic review.

Frontiers in veterinary science·2026

Same author

'<i>Is anyone else's husband trying to undermine them all the time?</i>': A reflexive thematic analysis of online support forum discussions about bariatric surgery saboteurs.

Journal of health psychology·2025

Same author

A Thematic Analysis of Motivators and Barriers to Antimicrobial Resistance Interventions With Farmers and Animal Health Professionals in Nigeria.

Veterinary medicine international·2025

Same author

Adult pain scores in the emergency department: a scoping review protocol.

BMJ open·2025

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Taking Orlistat: Predicting Weight Loss over 6 Months.

Amelia Hollywood¹, Jane Ogden

¹Department of Psychology, University of Surrey, Guildford, Surrey GU2 7XH, UK.

Journal of Obesity

|November 30, 2010

Summary

Orlistat aids weight loss by prompting dietary changes, especially when side effects encourage focus on eating behaviors. Clinicians should frame these consequences as educational to enhance treatment effectiveness.

Area of Science:

Pharmacology
Behavioral Science
Obesity Research

Background:

Orlistat is a medication used for weight management.
Understanding predictors of weight loss is crucial for optimizing treatment.
Patient beliefs and behaviors significantly influence treatment outcomes.

Purpose of the Study:

To identify baseline predictors of weight loss with orlistat.
To examine how changes in beliefs and behaviors affect weight loss.
To explore patient perceptions and usage patterns of orlistat.

Main Methods:

A cohort of 566 patients prescribed orlistat completed questionnaires at baseline and 6 months.
Data collected included weight, beliefs, and eating behaviors.
Statistical analysis explored relationships between variables and weight loss.

More Related Videos

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

Main Results:

The majority of patients experienced weight loss and improved diet after 6 months.
Significant weight loss correlated with decreased belief in medical solutions, reduced unhealthy eating, and increased belief in treatment control.
Unpleasant side effects, like anal leakage, were associated with increased focus on behavioral changes and acceptance of consequences as educational.

Conclusions:

Orlistat's effectiveness in weight loss is influenced by patient-reported changes in beliefs and behaviors.
Adverse effects can serve as educational tools, promoting adherence to dietary changes.
Clinicians should leverage these side effects as educational opportunities to enhance orlistat's therapeutic impact.